227 related articles for article (PubMed ID: 16753184)
21. Why are prion diseases precluded by non-mammals?
Ji HF; Zhang HY; Chen LL
Trends Biochem Sci; 2007 May; 32(5):206-8; discussion 208. PubMed ID: 17419063
[No Abstract] [Full Text] [Related]
22. Mechanisms of prion disease progression: a chemical reaction network approach.
Méndez JM; Femat R
IET Syst Biol; 2011 Nov; 5(6):347-52. PubMed ID: 22129030
[TBL] [Abstract][Full Text] [Related]
23. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract.
Petrakis S; Irinopoulou T; Panagiotidis CH; Engelstein R; Lindstrom J; Orr-Urtreger A; Gabizon R; Grigoriadis N; Sklaviadis T
Eur J Neurosci; 2008 Feb; 27(3):612-20. PubMed ID: 18279314
[TBL] [Abstract][Full Text] [Related]
24. Modeling of a propagation mechanism of infectious prion protein; a hexamer as the minimum infectious unit.
Nakamura HK; Takano M; Kuwata K
Biochem Biophys Res Commun; 2007 Sep; 361(3):789-93. PubMed ID: 17678874
[TBL] [Abstract][Full Text] [Related]
25. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
[TBL] [Abstract][Full Text] [Related]
26. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
27. [Prion protein and copper: a mysterious relationship].
Rachidi W; Riondel J; McMahon HM; Favier A
Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
[TBL] [Abstract][Full Text] [Related]
28. Toward a mechanism of prion misfolding and structural models of PrP(Sc): current knowledge and future directions.
Guest WC; Plotkin SS; Cashman NR
J Toxicol Environ Health A; 2011; 74(2-4):154-60. PubMed ID: 21218344
[TBL] [Abstract][Full Text] [Related]
29. Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer.
Masel J; Genoud N; Aguzzi A
J Mol Biol; 2005 Feb; 345(5):1243-51. PubMed ID: 15644218
[TBL] [Abstract][Full Text] [Related]
30. Detection of prions in blood.
Castilla J; Saá P; Soto C
Nat Med; 2005 Sep; 11(9):982-5. PubMed ID: 16127436
[TBL] [Abstract][Full Text] [Related]
31. Prion proteins: a biological role beyond prion diseases.
Hu W; Rosenberg RN; Stüve O
Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
[TBL] [Abstract][Full Text] [Related]
32. Methionine sulfoxides on PrPSc: a prion-specific covalent signature.
Canello T; Engelstein R; Moshel O; Xanthopoulos K; Juanes ME; Langeveld J; Sklaviadis T; Gasset M; Gabizon R
Biochemistry; 2008 Aug; 47(34):8866-73. PubMed ID: 18680312
[TBL] [Abstract][Full Text] [Related]
33. The effect of the osmolyte trimethylamine N-oxide on the stability of the prion protein at low pH.
Granata V; Palladino P; Tizzano B; Negro A; Berisio R; Zagari A
Biopolymers; 2006 Jun; 82(3):234-40. PubMed ID: 16489585
[TBL] [Abstract][Full Text] [Related]
34. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
Surewicz WK; Jones EM; Apetri AC
Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
[TBL] [Abstract][Full Text] [Related]
35. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
36. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
Gilch S; Nunziante M; Ertmer A; Schätzl HM
Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
[TBL] [Abstract][Full Text] [Related]
37. Dynamic simulation of the mouse prion protein.
Guilbert C; Ricard F; Smith JC
Biopolymers; 2000 Nov; 54(6):406-15. PubMed ID: 10951327
[TBL] [Abstract][Full Text] [Related]
38. One gene, two diseases and three conformations: molecular dynamics simulations of mutants of human prion protein at room temperature and elevated temperatures.
Shamsir MS; Dalby AR
Proteins; 2005 May; 59(2):275-90. PubMed ID: 15739202
[TBL] [Abstract][Full Text] [Related]
39. Photo-induced crosslinking of prion protein oligomers and prions.
Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
[TBL] [Abstract][Full Text] [Related]
40. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
